Venture
Lycia Therapeutics, Inc.
Latest Form D 2026-06-25- CIK 1806540
- State CA
- Biotechnology
- 4 Form D offerings since 2020-03-17
- Total sold
- $277M
- across 4 offerings
- Rounds
- 4
- Form D offerings since 2020-03-17
- Latest round
- $75M
- 2026-06-25 · 021-588627
- Investors
- 16
- on the latest round
Connected
named in its Form D filingsRound timeline
amount sold · by first filed2026-06-25 · $75M
- 2020-03-17$25.4M021-363038
- 2021-09-16$70.1M021-413559
- 2024-05-23$107M021-514102
- 2026-06-25$75M021-588627
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($107M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-588627 | First filed2026-06-25 | Latest2026-06-25 | Sought$75M | Sold$75M | Investors16 | Exemptions506(b) |
| 021-514102 | First filed2024-05-23 | Latest2024-05-23 | Sought$107M | Sold$107M | Investors16 | Exemptions506(b) |
| 021-413559 | First filed2021-09-16 | Latest2021-09-16 | Sought$70.1M | Sold$70.1M | Investors11 | Exemptions506(b) |
| 021-363038 | First filed2020-03-17 | Latest2020-03-17 | Sought$50.4M | Sold$25.4M | Investors1 | Exemptions506(b) |
Who backs Lycia Therapeutics, Inc. — 4 inferred investors — and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2026-06-25
| Name | Relationship |
|---|---|
| William Rieflin | RelationshipDirector |
| Clare Ozawa | RelationshipDirector |
| Ming Fang | RelationshipDirector |
| Laurent Fischer | RelationshipDirector |
| Tim Anderson | RelationshipDirector |
| Aetna Wun Trombley | RelationshipExecutive Officer, Director |
| Amy Bachrodt | RelationshipExecutive Officer |
Facts
As its latest Form D states them
- Industry
- Biotechnology
- State
- California (CA)
- Exemptions
- Rule 506(b)
- First filed
- 2020-03-17
- Latest filing
- 2026-06-25
Who backs Lycia Therapeutics, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plansExternal link: SEC Filings ↗